475 related articles for article (PubMed ID: 19422477)
1. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
[TBL] [Abstract][Full Text] [Related]
2. Relationship between hepatocellular carcinoma and impaired glucose tolerance among Japanese.
Khan MM; Saito S; Takagi S; Ohnishi H; Izumi H; Sakauchi F; Washio M; Sonoda T; Nagata Y; Asakura S; Kobayashi K; Mori M; Shimamoto K
Hepatogastroenterology; 2006; 53(71):742-6. PubMed ID: 17086880
[TBL] [Abstract][Full Text] [Related]
3. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.
Nishida T; Tsuji S; Tsujii M; Arimitsu S; Haruna Y; Imano E; Suzuki M; Kanda T; Kawano S; Hiramatsu N; Hayashi N; Hori M
Am J Gastroenterol; 2006 Jan; 101(1):70-5. PubMed ID: 16405536
[TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
Arao M; Murase K; Kusakabe A; Yoshioka K; Fukuzawa Y; Ishikawa T; Tagaya T; Yamanouchi K; Ichimiya H; Sameshima Y; Kakumu S
J Gastroenterol; 2003; 38(4):355-60. PubMed ID: 12743775
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
Huang JF; Yu ML; Dai CY; Hsieh MY; Hwang SJ; Hsiao PJ; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL
Am J Gastroenterol; 2008 Aug; 103(8):1933-40. PubMed ID: 18637090
[TBL] [Abstract][Full Text] [Related]
10. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.
Custro N; Carroccio A; Ganci A; Scafidi V; Campagna P; Di Prima L; Montalto G
Diabetes Metab; 2001 Sep; 27(4 Pt 1):476-81. PubMed ID: 11547221
[TBL] [Abstract][Full Text] [Related]
11. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
13. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia.
Hayashi J; Furusyo N; Ariyama I; Sawayama Y; Etoh Y; Kashiwagi S
J Infect Dis; 2000 May; 181(5):1523-7. PubMed ID: 10823749
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and clinical aspects on hepatitis C.
Higuchi M; Tanaka E; Kiyosawa K
Jpn J Infect Dis; 2002 Jun; 55(3):69-77. PubMed ID: 12195046
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
Mowla A; Karimi M; Afrasiabi A; De Sanctis V
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
[TBL] [Abstract][Full Text] [Related]
18. [A survey of diabetes mellitus among inpatients in Guangdong province].
Guangdong Diabetes Socitety of Medical Association
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):815-8. PubMed ID: 16681969
[TBL] [Abstract][Full Text] [Related]
19. Glucose tolerance before and after renal transplantation.
Bergrem HA; Valderhaug TG; Hartmann A; Bergrem H; Hjelmesaeth J; Jenssen T
Nephrol Dial Transplant; 2010 Mar; 25(3):985-92. PubMed ID: 19854851
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
